Kortylewski Marcin 13D/13G Filings for Scopus BioPharma Inc. (SCPS)

Kortylewski Marcin 13D and 13G filings for Scopus BioPharma Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-07-12
8:20 pm
Purchase
2021-06-25 13G Scopus BioPharma Inc.
SCPS
Kortylewski Marcin 911,079
5.000%
911,079increase
(New Position)
Filing